13F
← All fund report cards

PRINCIPAL FINANCIAL GROUP INC

13F equity value
$187.2B
Positions
2,177
Top 10 concentration
19.8%
Quarters / total new picks
32 / 1,664
13F equity value over time
$0M$99B$198B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +2.5% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 40.6% of quarters (excess t = 0.46, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
+0.8%
t-stat
0.46
Quarterly win rate
41%
Annualized excess
-3.0%
$1 → follow vs universe
$1.67 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.03620180630: follow 0.90620180930: follow 0.97720181231: follow 0.95620190331: follow 0.93720190630: follow 0.94920190930: follow 1.03920191231: follow 0.82520200331: follow 1.07420200630: follow 1.22020200930: follow 1.49920201231: follow 1.35320210331: follow 1.45720210630: follow 1.68720210930: follow 1.16320211231: follow 0.96520220331: follow 0.99020220630: follow 0.88420220930: follow 0.95320221231: follow 0.86220230331: follow 0.92620230630: follow 0.83420230930: follow 1.02820231231: follow 1.07020240331: follow 1.21620240630: follow 1.50120240930: follow 1.44620241231: follow 1.40320250331: follow 1.51020250630: follow 1.52120250930: follow 1.71020251231: follow 1.670 0.76 1.51 2.25 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 2177 · 2026 Q1

Ticker Value Weight QoQ
NVDA $6.9B
3.7%
ADD
MSFT $5.6B
3.0%
HOLD
AAPL $5.4B
2.9%
HOLD
AMZN $4.0B
2.1%
TRIM
GOOGL $3.2B
1.7%
HOLD
AVGO $2.7B
1.4%
ADD
BN $2.6B
1.4%
HOLD
META $2.4B
1.3%
ADD
TDG $2.3B
1.3%
TRIM
GOOG $2.1B
1.1%
ADD
HLT $2.0B
1.1%
TRIM
EQIX $1.9B
1.0%
HOLD
USMC $1.9B
1.0%
TRIM
WELL $1.9B
1.0%
TRIM
HEI/A $1.9B
1.0%
TRIM
VMC $1.8B
1.0%
TRIM
KKR $1.8B
1.0%
ADD
LYV $1.7B
0.9%
ADD
ORLY $1.7B
0.9%
TRIM
IVV $1.6B
0.9%
ADD

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.